A PET scan detects abnormal cellular activity in the body, making it a powerful tool for diagnosing cancer, neurological conditions, heart disease, and inflammatory disorders. Unlike CT or MRI scans that show the shape and structure of organs, a PET scan reveals how your cells are functioning, often catching problems before any structural changes appear.
How a PET Scan Works
A PET scan uses a small amount of radioactive tracer, most commonly a modified form of glucose, injected into your vein. Because cells need glucose for energy, the tracer travels through your body and collects wherever cells are most active. Cancer cells, inflamed tissue, and certain brain regions consume glucose at unusually high rates, so they light up on the scan. A special camera then captures this activity and produces a detailed 3D image of what’s happening inside your body at the cellular level.
This is the key difference between PET and other imaging. A CT scan takes cross-sectional images showing the shape of organs, bones, and blood vessels. An MRI uses magnets and radio waves to create detailed pictures of soft tissue. Both show structure. A PET scan shows function: which cells are burning through energy and which are not. That distinction matters because metabolic changes often appear before a tumor grows large enough to show up on a CT or MRI.
Cancer Detection and Staging
Cancer is the most common reason for a PET scan. The scan is routinely used for lung cancer, breast cancer, thyroid cancer, lymphoma, colorectal cancer, melanoma, and many other malignancies. Because cancer cells divide rapidly, they consume far more glucose than normal tissue, making them easy to spot on the scan as bright areas of high activity.
Beyond simply finding a tumor, PET scans answer three critical questions that shape treatment decisions. First, has the cancer spread? A whole-body PET scan can reveal whether cancer cells have reached lymph nodes, bones, or distant organs. Second, is treatment working? Doctors can compare scans taken before and after chemotherapy or radiation to see whether the cancer’s metabolic activity has decreased. Third, has the cancer come back? If blood tests or symptoms suggest a recurrence, a PET scan can locate it.
For prostate cancer specifically, a newer type of PET scan targets a protein found on prostate cancer cells rather than relying on glucose uptake. This scan can detect prostate cancer anywhere in the body and is particularly useful when there’s concern the cancer has spread beyond the prostate or when signs suggest the cancer has returned after treatment. The results also help determine whether a specific targeted therapy is likely to work: if the tracer builds up in the cancer cells, that therapy may be effective, and if it doesn’t, doctors know to pursue other options.
Neurological Conditions
PET scans play a significant role in diagnosing Alzheimer’s disease and other forms of dementia. Specialized tracers can now visualize the amyloid plaques that accumulate in the brains of Alzheimer’s patients, allowing doctors to confirm the diagnosis in living patients rather than relying solely on cognitive testing and clinical observation. The standard glucose-based PET scan also helps by revealing characteristic patterns of reduced brain activity in regions affected by different types of dementia, helping distinguish Alzheimer’s from other causes of cognitive decline.
For epilepsy, PET scanning is considered the most sensitive imaging technique for locating the brain region where seizures originate. This matters most for people whose seizures don’t respond to medication and who are considering surgery. The scan identifies the seizure focus by showing an area of reduced metabolism between seizures. In temporal lobe epilepsy, PET correctly identifies the seizure-producing region in 85 to 90 percent of cases. It’s especially valuable when MRI results are normal or ambiguous: in one study, PET successfully identified the seizure focus in 84 percent of patients whose MRI showed nothing abnormal. The scan does have limits, though. The area of reduced metabolism can extend beyond the actual seizure zone, so PET alone can’t define exact surgical boundaries.
Heart Disease
PET scans help cardiologists answer a specific and important question after a heart attack: is the damaged heart muscle still alive? When part of the heart loses blood flow, the muscle can enter a state called hibernation, where it stops contracting but remains viable. If blood flow is restored through surgery, that muscle can recover. If the muscle is truly dead, surgery won’t help.
A PET scan distinguishes between these two scenarios by comparing blood flow and metabolic activity. When an area of the heart has poor blood flow but still takes up glucose actively, it signals hibernating muscle that could benefit from treatment. When both blood flow and glucose uptake are equally reduced, the tissue is no longer viable. This information directly influences whether a patient is referred for a bypass or stent procedure, making it one of the most consequential uses of PET imaging.
Inflammatory and Infectious Diseases
Inflammatory cells burn through glucose at high rates, which makes PET scans useful for detecting and monitoring conditions that involve widespread inflammation. Sarcoidosis, a disease where clusters of immune cells form granulomas throughout the body, is one of the best examples. PET scanning can identify sarcoidosis activity in the lungs, bones, liver, spleen, and lymph nodes, sometimes revealing disease in locations that other tests miss entirely. In one review, PET scan findings changed the clinical management plan in 63 percent of sarcoidosis patients.
Cardiac sarcoidosis deserves special mention because it can be life-threatening and sometimes produces no symptoms. PET scanning can detect inflammatory activity in the heart when other tests are inconclusive, or when a patient can’t undergo an MRI due to an implanted cardiac device. Beyond diagnosis, doctors also use PET to monitor whether treatment is reducing inflammation over time, track disease severity, and identify the best sites for biopsy when tissue confirmation is needed.
What to Expect During the Scan
You’ll need to fast for six hours before your appointment, drinking only plain water. When you arrive, a technician will check your blood sugar (it needs to fall between 70 and 200 mg/dL) and then inject the tracer into a vein in your arm. You’ll sit quietly for about 60 minutes while the tracer distributes through your body. Physical activity or even talking too much during this waiting period can cause muscles to absorb extra tracer and interfere with the images.
The scan itself takes 15 to 45 minutes depending on which part of the body is being imaged. You’ll lie still on a table that slides through a ring-shaped scanner. Most facilities now use combined PET/CT machines, which capture both metabolic and structural images in a single session, giving doctors a more complete picture.
Radiation Exposure
A standard PET scan delivers about 8 millisieverts of radiation, roughly equivalent to two to three years of natural background radiation. When combined with a CT scan in the same session, the total dose increases. For context, a standard chest CT alone delivers about 7 millisieverts. The tracer is short-lived and leaves your body primarily through urine within several hours. Drinking extra water after the scan helps clear it faster.